Physician profile
Yana Yazmir
NPI 1841815370
$5,628.01
in general payments reported to CMS, 2019-2025
26 companies · $2,899 in 2025
The $2,899 reported for 2025 was more than what 96% of Gerontology (Registered Nurse) providers received nationally (typical 2025 total: $85.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $955 · 2023: $380 · 2024: $1,394 · 2025: $2,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,976 · Travel and Lodging: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,975.78 |
| Travel and Lodging | $697.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,250.94 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Astrazeneca Pharmaceuticals Lp | $623.40 | 2022-2025 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $466.49 | 2022-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $386.41 | 2022-2025 | Verquvo |
| Impulse Dynamics (USA) INC. | $348.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.62 | 2022-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $180.42 | 2025 | Assure Wcd |
| Pfizer INC. | $160.10 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $156.92 | 2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $134.85 | 2023-2025 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $129.42 | 2023-2024 | Inpefa |
| Novartis Pharmaceuticals Corporation | $115.67 | 2022-2025 | |
| La Jolla Pharmaceutical Company | $95.21 | 2024-2025 | Giapreza |
| Scpharmaceuticals INC. | $70.29 | 2023-2025 | |
| Edwards Lifesciences Corporation | $56.55 | 2023-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $40.32 | 2025 | |
| Teleflex LLC | $36.94 | 2024 | Manta |
| Bridgebio Pharma, INC. | $35.93 | 2025 | Attruby |
| United Therapeutics Corporation | $21.79 | 2024 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $20.33 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $18.52 | 2024 | Arcalyst |
| Watermark Medical, INC. | $18.02 | 2025 | |
| Cvrx, INC. | $17.81 | 2025 | Barostim Neo System |
| Becton, Dickinson and Company | $17.74 | 2025 | Arista |
| Medicomp INC | $14.14 | 2024 | Telepatch Cardiac Monitor |
| Paladin Technology Solutions | $14.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yana Yazmir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.